February 2026
M	T	W	T	F	S	S
	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Charles Okyere Boadu: Safe Blood Saves Lives, Safer Blood Protects Futures

Charles Okyere Boadu/LinkedIn

Feb 10, 2026, 14:25

Charles Okyere Boadu: Safe Blood Saves Lives, Safer Blood Protects Futures

Charles Okyere Boadu, Medical Laboratory Science Student at the University for Development Studies, shared on LinkedIn:

”As a medical laboratory professional, I have come to appreciate how critical blood donor screening is to transfusion safety.

The primary responsibility of transfusion services is to ensure that blood released for transfusion is as safe as possible, since transfusion-transmissible infections remain a major public health concern.

In many health facilities, rapid diagnostic tests (RDTs) are routinely used to screen donated blood for transfusion-transmissible infections such as HIV, hepatitis B, hepatitis C, and syphilis. These tests are commonly employed in emergency situations and resource-constrained centers because they are easy to use and provide results quickly.

When RDT results are non-reactive and all other donor screening criteria are met, the blood is often considered safe and released for transfusion.

However, it is important to note that RDTs have limitations.

Although high-quality, validated RDTs can demonstrate excellent sensitivity, they may still fail to detect infection in certain situations.

When the level of analyte such as viral antigen or antibody is very low, particularly during early infection or the window period, the test may not detect it, resulting in a non-reactive result despite the presence of infection.

False-negative results may occur due to early testing, low viral load, viral variants, or other biological factors(Choudhary et al., 2025).

This is why I believe public awareness is crucial.

It could be me, you, or one of our relatives receiving blood someday. Whenever possible, especially before transfusion, it is reasonable to ask whether additional or confirmatory testing such as ELISA has been performed alongside RDT screening.

ELISA is widely regarded as the gold standard for blood donor screening because it allows objective interpretation, quality control monitoring, and reliable detection of transfusion transmissible infections (Choudhary et al., 2025).

I understand that ELISA testing requires more time, and many patients who need blood are in critical condition where delays can be life-threatening.

Nevertheless, ensuring the highest possible level of blood safety remains essential, as a patient may receive blood, recover, and later develop an infection without ever knowing the source.

This is not to discredit RDTs. Rather, this is a call to encourage layered testing, appropriate use of confirmatory methods, and informed decision-making in transfusion practice, as integrating multiple testing strategies has been shown to improve overall blood safety.

Safe blood saves lives. Safer blood protects futures.”

Charles Okyere Boadu: Safe Blood Saves Lives, Safer Blood Protects Futures